The Prognostic Value of BRAF, C-KIT, and NRAS Mutations in Melanoma Patients With Brain Metastases Conference

Sperduto, Paul W, Jiang, Wen, Brown, Paul D et al. (2017). The Prognostic Value of BRAF, C-KIT, and NRAS Mutations in Melanoma Patients With Brain Metastases . INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 98(5), 1069-1077. 10.1016/j.ijrobp.2017.03.030

Open Access International Collaboration

cited authors

  • Sperduto, Paul W; Jiang, Wen; Brown, Paul D; Braunstein, Steve; Sneed, Penny; Wattson, Daniel A; Shih, Helen A; Bangdiwala, Ananta; Shanley, Ryan; Lockney, Natalie A; Beal, Kathryn; Lou, Emil; Amatruda, Thomas; Sperduto, William A; Kirkpatrick, John P; Yeh, Norman; Gaspar, Laurie E; Molitoris, Jason K; Masucci, Laura; Roberge, David; Yu, James; Chiang, Veronica; Mehta, Minesh

sustainable development goals

authors

publication date

  • August 1, 2017

published in

keywords

  • CANCER
  • IMPROVED SURVIVAL
  • INHIBITION
  • IPILIMUMAB
  • LUNG
  • Life Sciences & Biomedicine
  • Oncology
  • PEMBROLIZUMAB
  • RADIATION-THERAPY
  • Radiology, Nuclear Medicine & Medical Imaging
  • STEREOTACTIC RADIOSURGERY
  • Science & Technology
  • VEMURAFENIB

Digital Object Identifier (DOI)

publisher

  • ELSEVIER SCIENCE INC

start page

  • 1069

end page

  • 1077

volume

  • 98

issue

  • 5